DanCann Pharma A/S Provides Positive Insight on Progress of Cannabis Bulk Product Approval
COPENHAGEN, Denmark, 14 March 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby provides positive insight on the progress of cannabis bulk product (the “Product” or “Cannabis Flos”) approval from its EU-GMP facility, Biotech Pharm1.DanCann Pharma has established a new benchmark in the cannabis industry by completing additional microbial testing in conjunction with a microbial suitability and verification study. Results from the testing showed levels 5,000 times lower than the legal requirements. To